Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs VIVANZA BIOSCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS VIVANZA BIOSCIENCES NOVARTIS/
VIVANZA BIOSCIENCES
 
P/E (TTM) x 85.8 123.1 69.7% View Chart
P/BV x 2.7 24.0 11.2% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   VIVANZA BIOSCIENCES
EQUITY SHARE DATA
    NOVARTIS
Mar-21
VIVANZA BIOSCIENCES
Mar-21
NOVARTIS/
VIVANZA BIOSCIENCES
5-Yr Chart
Click to enlarge
High Rs770180 426.9%   
Low Rs50112 4,024.1%   
Sales per share (Unadj.) Rs154.524.7 624.8%  
Earnings per share (Unadj.) Rs8.50.2 4,514.6%  
Cash flow per share (Unadj.) Rs13.40.2 6,301.2%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.27.9 3,661.3%  
Shares outstanding (eoy) m24.694.00 617.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.13.9 105.5%   
Avg P/E ratio x75.1512.4 14.7%  
P/CF ratio (eoy) x47.5452.3 10.5%  
Price / Book Value ratio x2.212.2 18.0%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,691386 4,069.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0853 32,008.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81499 3,856.7%  
Other income Rs m3325 6,574.3%   
Total revenues Rs m4,146104 3,988.4%   
Gross profit Rs m2671 26,156.9%  
Depreciation Rs m1220 121,600.0%   
Interest Rs m775 1,620.3%   
Profit before tax Rs m4001 32,552.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 39,875.0%   
Profit after tax Rs m2091 27,866.7%  
Gross profit margin %7.01.0 675.2%  
Effective tax rate %47.839.1 122.1%   
Net profit margin %5.50.8 719.3%  
BALANCE SHEET DATA
Current assets Rs m9,22450 18,391.8%   
Current liabilities Rs m3,57353 6,756.1%   
Net working cap to sales %148.2-2.8 -5,359.6%  
Current ratio x2.60.9 272.2%  
Inventory Days Days17641 430.9%  
Debtors Days Days37230,729,704 0.0%  
Net fixed assets Rs m2,48034 7,223.4%   
Share capital Rs m12340 308.5%   
"Free" reserves Rs m7,018-8 -83,547.6%   
Net worth Rs m7,14132 22,599.4%   
Long term debt Rs m00-   
Total assets Rs m11,70384 13,855.0%  
Interest coverage x6.21.3 492.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.31.2 27.8%   
Return on assets %2.46.5 37.5%  
Return on equity %2.92.4 122.8%  
Return on capital %6.718.9 35.3%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-28 2,504.0%  
From Investments Rs m952NA -453,142.9%  
From Financial Activity Rs m-36825 -1,489.9%  
Net Cashflow Rs m-109-3 3,433.5%  

Share Holding

Indian Promoters % 0.0 47.8 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 52.2 56.2%  
Shareholders   45,141 4,619 977.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TINNA TRADE  P.M. TELELINNKS  MYSTIC ELECTRONICS  ADANI TRANSMISSION  SREELEATHERS  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 26, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS